Skip to content
DataLookout
Menu

NCT03789253

Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion moved earlier from Jul 31, 2030 to Jul 31, 2028
    • Eligibility criteria expanded, about 5 words
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Dec 31, 2021 to Jul 31, 2030
    • Primary endpoint revised
    • Study sites: 0 to 1
    v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Gene expression
Timeframe: 3 years

Arms and interventions

AS cohort with progression

AS cohort with tumor progression

AS cohort without progression

AS cohort without tumor progression

Sites

1 site in 1 country

  • National Taiwan UniversityTaipei, Taiwan